Maged Shenouda Insider Trading
Get free email notifications about insider trading for Maged Shenouda.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Maged Shenouda. Maged Shenouda is a Director in Protea Biosciences Group, Inc. ($PRGB) and a CFO in RELMADA THERAPEUTICS, INC. ($RLMD) and a Director in RELMADA THERAPEUTICS, INC. ($RLMD) and a in AzurRx BioPharma, Inc. ($AZRX) and a CHIEF FINANCIAL OFFICER in AzurRx BioPharma, Inc. ($AZRX).
Address: C/O RELMADA THERAPEUTICS, INC. 757 THIRD AVENUE, SUITE 2018 NEW YORK 10017 NY
Companies in which Maged Shenouda is an Insider
AzurRx BioPharma, Inc.
Trading Symbol: AZRXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Maged Shenouda: CHIEF FINANCIAL OFFICER
Holdings: 62,500 shares
Current Value: $265,625
Latest Transaction: Jan 02 2019
$AZRX Market Capitalization: $38.52M
$AZRX Previous Close: $4.25
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Protea Biosciences Group, Inc.
Trading Symbol: PRGBIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Maged Shenouda: Director
Holdings: 100,000 shares
Current Value: $11,000
Latest Transaction: Jan 07 2016
$PRGB Market Capitalization: $13.44M
$PRGB Previous Close: $0.11
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
RELMADA THERAPEUTICS, INC.
Trading Symbol: RLMDIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Maged Shenouda: CFO, Director
Holdings: 12,228 shares
Current Value: $13,329
Latest Transaction: Mar 10 2021
$RLMD Market Capitalization: $12.16M
$RLMD Previous Close: $1.09
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Maged Shenouda
Sentiment: All, AZRX, PRGB, RLMD
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 10 2021 | RLMD | RELMADA THERAPEUTI ... | Shenouda Maged | CFO | Option Exercise | M | 3.24 | 10,000 | 32,400 | 70,350 | |
Mar 10 2021 | RLMD | RELMADA THERAPEUTI ... | Shenouda Maged | CFO | Sell | S | 35.11 | 2,373 | 83,313 | 2,228 | 4.6 K to 2.2 K (-51.58 %) |
Mar 10 2021 | RLMD | RELMADA THERAPEUTI ... | Shenouda Maged | CFO | Sell | S | 36.02 | 1,800 | 64,836 | 4,601 | 6.4 K to 4.6 K (-28.12 %) |
Mar 10 2021 | RLMD | RELMADA THERAPEUTI ... | Shenouda Maged | CFO | Sell | S | 35.42 | 5,727 | 202,857 | 6,401 | 12.1 K to 6.4 K (-47.22 %) |
Mar 10 2021 | RLMD | RELMADA THERAPEUTI ... | Shenouda Maged | CFO | Sell | S | 35.00 | 100 | 3,500 | 12,128 | 12.2 K to 12.1 K (-0.82 %) |
Mar 10 2021 | RLMD | RELMADA THERAPEUTI ... | Shenouda Maged | CFO | Buy | M | 3.24 | 10,000 | 32,400 | 12,228 | 2.2 K to 12.2 K (+448.83 %) |
Feb 16 2021 | RLMD | RELMADA THERAPEUTI ... | Shenouda Maged | CFO | Option Exercise | M | 3.24 | 1,428 | 4,627 | 83,250 |